title: Lymphangioleiomyomatosis--a brief review and estimation of excess risk.
abstract: Lymphangioleiomyomatosis (LAM) is a rare pulmonary disease in women of child-bearing age. It is multisystem disease and affects mainly the lungs. A recently published Korean medical article showed a sharp increase of LAM patients in Korea since 2004. LAM is not discussed in the standard textbook of insurance medicine. This article will briefly review LAM and estimate excess risk derived from recently published articles.
authors.affiliation: Samsung Life Service Co. 10th Fl. Samsung-Jeil Bldg, 702-2, Yeoksam-Dong, Gangnam-Gu, Seoul, Korea, 135-751. sinhyung.lee@samsung.com
authors.forename: Sinhyung
authors.initials: S
authors.lastname: Lee
mesh_terms: D000328:Adult; D000367:Age Factors; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000196:embryology / Q000401:mortality*; D018192:Lymphangioleiomyomatosis / Q000453:epidemiology / Q000401:mortality*; D008875:Middle Aged; D015995:Prevalence; D056910:Republic of Korea / Q000453:epidemiology; D012307:Risk Factors